Showing results 15 to 32 of 32
< previous
Issue Date | Title | Author(s) |
2012-05-23 | M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection | Blumenthal, A; Nagalingam, G; Huch, JH; Walker, L; Guillemin, GJ; Smythe, GA; Ehrt, S; Britton, WJ; Saunders, BM |
2021-11 | Macrophages of different tissue origin exhibit distinct inflammatory responses to mycobacterial infection. | Stevens, MT; Nagaria, BD; Britton, WJ; Saunders, BM |
2013-01-15 | Microparticles from mycobacteria-infected macrophages promote inflammation and cellular migration | Walters, SB; Kieckbusch, J; Nagalingam, G; Swain, A; Latham, SL; Grau, GER; Britton, WJ; Combes, V; Saunders, BM |
2015-09-01 | Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15 | Hare, NJ; Chan, B; Chan, E; Kaufman, KL; Britton, WJ; Saunders, BM |
2017-09-01 | Modulation of roquin function in myeloid cells reduces mycobacterium tuberculosis-induced inflammation | Nagalingam, G; Vinuesa, CG; Britton, WJ; Saunders, BM |
2022-06 | Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2. | Stewart, EL; Counoupas, C; Johansen, MD; Nguyen, DH; Miemczyk, S; Hansbro, NG; Ferrell, KC; Ashhurst, A; Alca, S; Ashley, C; Steain, M; Britton, WJ; Hansbro, PM; Petrovsky, N; Triccas, JA |
2022-11-15 | Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice. | Ashhurst, AS; Johansen, MD; Maxwell, JWC; Stockdale, S; Ashley, CL; Aggarwal, A; Siddiquee, R; Miemczyk, S; Nguyen, DH; Mackay, JP; Counoupas, C; Byrne, SN; Turville, S; Steain, M; Triccas, JA; Hansbro, PM; Payne, RJ; Britton, WJ |
2021-04-07 | Mycobacterial infection-induced miR-206 inhibits protective neutrophil recruitment via the CXCL12/CXCR4 signalling axis | Wright, K; de Silva, K; Plain, KM; Purdie, AC; Blair, TA; Duggin, IG; Britton, WJ; Oehlers, SH |
2018-11 | Mycobacterium marinum infection drives foam cell differentiation in zebrafish infection models. | Johansen, MD; Kasparian, JA; Hortle, E; Britton, WJ; Purdie, AC; Oehlers, SH |
2017-01-06 | Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and Their Microparticles | Hare, NJ; Lee, LY; Loke, I; Britton, WJ; Saunders, BM; Thaysen-Andersen, M |
2022-06-30 | No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis. | Quan, DH; Kwong, AJ; Hansbro, PM; Britton, WJ |
2022-09 | OXSR1 inhibits inflammasome activation by limiting potassium efflux during mycobacterial infection. | Hortle, E; Tran, VL; Wright, K; Fontaine, AR; Pinello, N; O'Rourke, MB; Wong, JJ-L; Hansbro, PM; Britton, WJ; Oehlers, SH |
2014-07-09 | Polymorphisms of SP110 are associated with both pulmonary and extra-pulmonary tuberculosis among the Vietnamese | Fox, GJ; Sy, DN; Nhung, NV; Yu, B; Ellis, MK; Van Hung, N; Cuong, NK; Lien, LT; Marks, GB; Saunders, BM; Britton, WJ |
2022-02-17 | Rough and smooth variants of Mycobacterium abscessus are differentially controlled by host immunity during chronic infection of adult zebrafish. | Kam, JY; Hortle, E; Krogman, E; Warner, SE; Wright, K; Luo, K; Cheng, T; Manuneedhi Cholan, P; Kikuchi, K; Triccas, JA; Britton, WJ; Johansen, MD; Kremer, L; Oehlers, SH |
2001-01-15 | Secreted lymphotoxin-α is essential for the control of an intracellular bacterial infection | Roach, DR; Briscoe, H; Saunders, B; France, MP; Riminton, S; Britton, WJ |
2021-12-09 | Synthetic Sansanmycin Analogues as Potent Mycobacterium tuberculosis Translocase I Inhibitors. | Tran, W; Kusay, AS; Hawkins, PME; Cheung, C-Y; Nagalingam, G; Pujari, V; Ford, DJ; Stoye, A; Ochoa, JL; Audette, RE; Hortle, E; Oehlers, SH; Charman, SA; Linington, RG; Rubin, EJ; Dowson, CG; Roper, DI; Crick, DC; Balle, T; Cook, GM; Britton, WJ; Payne, RJ |
2019-05-01 | The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets. | Black, HD; Xu, W; Hortle, E; Robertson, SI; Britton, WJ; Kaur, A; New, EJ; Witting, PK; Chami, B; Oehlers, SH |
2022-09-30 | Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. | Vanka, KS; Shukla, S; Gomez, HM; James, C; Palanisami, T; Williams, K; Chambers, DC; Britton, WJ; Ilic, D; Hansbro, PM; Horvat, JC |